Antoine Bougouin
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Pan-cancer spatial atlas of tertiary lymphoid structures.
Journal: Science (New York, N.Y.)
Published: May 28, 2026
Author Correction: DC subsets and states unraveled across human juxtatumoral and malignant tissues.
Journal: Nature immunology
Published: January 20, 2026
Author Correction: DC subsets and states unraveled across human juxtatumoral and malignant tissues.
Journal: Nature immunology
Published: December 16, 2025
GABA promotes resistance to immunotherapy in patients with TLS-positive tumors.
Journal: Cancer cell
Published: July 10, 2025
Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study.
Journal: European urology
Published: March 24, 2025
Timing and location dictate monocyte fate and their transition to tumor-associated macrophages.
Journal: Science immunology
Published: July 26, 2024
Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study.
Journal: Molecular cancer
Published: December 05, 2023
DC subsets and states unraveled across human juxtatumoral and malignant tissues.
Journal: Nature immunology
Published: January 14, 2023
Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: September 27, 2022
Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 05, 2022
Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study.
Journal: Journal for immunotherapy of cancer
Published: April 23, 2022
Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression.
Journal: Nature cancer
Published: February 04, 2022
Last Updated: 09/26/2026